Iris Clothings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:51 am

Competitors of Iris Clothings Ltd

All Competitor Stocks of Iris Clothings Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:50 am

Below is a detailed analysis of the quarterly data for Iris Clothings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 37.40 Cr.. The value appears to be declining and may need further review. It has decreased from 40.20 Cr. (Mar 2025) to 37.40 Cr., marking a decrease of 2.80 Cr..
• For Expenses, as of Jun 2025, the value is 32.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.09 Cr. (Mar 2025) to 32.14 Cr., marking an increase of 0.05 Cr..
• For Operating Profit, as of Jun 2025, the value is 5.26 Cr.. The value appears to be declining and may need further review. It has decreased from 8.11 Cr. (Mar 2025) to 5.26 Cr., marking a decrease of 2.85 Cr..
• For OPM %, as of Jun 2025, the value is 14.06%. The value appears to be declining and may need further review. It has decreased from 20.17% (Mar 2025) to 14.06%, marking a decrease of 6.11%.
• For Other Income, as of Jun 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.12 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.09 Cr..
• For Interest, as of Jun 2025, the value is 0.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.09 Cr. (Mar 2025) to 0.58 Cr., marking a decrease of 0.51 Cr..
• For Depreciation, as of Jun 2025, the value is 1.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.01 Cr. (Mar 2025) to 1.08 Cr., marking an increase of 0.07 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.63 Cr.. The value appears to be declining and may need further review. It has decreased from 6.13 Cr. (Mar 2025) to 3.63 Cr., marking a decrease of 2.50 Cr..
• For Tax %, as of Jun 2025, the value is 27.55%. The value appears to be increasing, which may not be favorable. It has increased from 26.75% (Mar 2025) to 27.55%, marking an increase of 0.80%.
• For Net Profit, as of Jun 2025, the value is 2.63 Cr.. The value appears to be declining and may need further review. It has decreased from 4.48 Cr. (Mar 2025) to 2.63 Cr., marking a decrease of 1.85 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.14. The value appears to be declining and may need further review. It has decreased from 0.24 (Mar 2025) to 0.14, marking a decrease of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:07 am

Growth

Last Updated: September 5, 2025, 7:50 am

Balance Sheet

Last Updated: November 9, 2025, 2:16 pm

Below is a detailed analysis of the balance sheet data for Iris Clothings Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 22.00 Cr..
• For Reserves, as of Sep 2025, the value is 94.00 Cr.. The value appears strong and on an upward trend. It has increased from 66.00 Cr. (Mar 2025) to 94.00 Cr., marking an increase of 28.00 Cr..
• For Borrowings, as of Sep 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 50.00 Cr. (Mar 2025) to 27.00 Cr., marking a decrease of 23.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 21.00 Cr.. The value appears to be improving (decreasing). It has decreased from 24.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 3.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 180.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 157.00 Cr. (Mar 2025) to 180.00 Cr., marking an increase of 23.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 150.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2025) to 150.00 Cr., marking an increase of 20.00 Cr..
• For Total Assets, as of Sep 2025, the value is 180.00 Cr.. The value appears strong and on an upward trend. It has increased from 157.00 Cr. (Mar 2025) to 180.00 Cr., marking an increase of 23.00 Cr..

Notably, the Reserves (94.00 Cr.) exceed the Borrowings (27.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Iris Clothings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.61. This value is below the healthy minimum of 5. It has increased from 1.50 (Mar 24) to 1.61, marking an increase of 0.11.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.61. This value is below the healthy minimum of 5. It has increased from 1.50 (Mar 24) to 1.61, marking an increase of 0.11.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 3. It has increased from 2.24 (Mar 24) to 2.38, marking an increase of 0.14.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.09. It has increased from 8.48 (Mar 24) to 10.09, marking an increase of 1.61.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.09. It has increased from 8.48 (Mar 24) to 10.09, marking an increase of 1.61.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 17.93. It has increased from 14.95 (Mar 24) to 17.93, marking an increase of 2.98.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has increased from 3.24 (Mar 24) to 3.47, marking an increase of 0.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.70. This value is within the healthy range. It has increased from 2.49 (Mar 24) to 2.70, marking an increase of 0.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 2.02 (Mar 24) to 2.18, marking an increase of 0.16.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.61. This value is below the healthy minimum of 2. It has increased from 1.50 (Mar 24) to 1.61, marking an increase of 0.11.
• For PBDIT Margin (%), as of Mar 25, the value is 19.35. This value is within the healthy range. It has decreased from 21.67 (Mar 24) to 19.35, marking a decrease of 2.32.
• For PBIT Margin (%), as of Mar 25, the value is 15.05. This value is within the healthy range. It has decreased from 16.68 (Mar 24) to 15.05, marking a decrease of 1.63.
• For PBT Margin (%), as of Mar 25, the value is 12.17. This value is within the healthy range. It has decreased from 13.52 (Mar 24) to 12.17, marking a decrease of 1.35.
• For Net Profit Margin (%), as of Mar 25, the value is 8.97. This value is within the healthy range. It has decreased from 10.01 (Mar 24) to 8.97, marking a decrease of 1.04.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.94. This value is within the healthy range. It has decreased from 17.65 (Mar 24) to 15.94, marking a decrease of 1.71.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.51. This value is within the healthy range. It has decreased from 26.09 (Mar 24) to 23.51, marking a decrease of 2.58.
• For Return On Assets (%), as of Mar 25, the value is 8.37. This value is within the healthy range. It has decreased from 9.16 (Mar 24) to 8.37, marking a decrease of 0.79.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.45. This value is within the healthy range. It has decreased from 0.49 (Mar 24) to 0.45, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. There is no change compared to the previous period (Mar 24) which recorded 1.01.
• For Current Ratio (X), as of Mar 25, the value is 2.01. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 2.01, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 24) to 0.90, marking an increase of 0.16.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.22. This value is below the healthy minimum of 4. It has increased from 1.02 (Mar 24) to 2.22, marking an increase of 1.20.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.74. This value is within the healthy range. It has decreased from 6.88 (Mar 24) to 6.74, marking a decrease of 0.14.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.12. This value is within the healthy range. It has decreased from 4.18 (Mar 24) to 4.12, marking a decrease of 0.06.
• For Enterprise Value (Cr.), as of Mar 25, the value is 392.73. It has decreased from 635.64 (Mar 24) to 392.73, marking a decrease of 242.91.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has decreased from 5.21 (Mar 24) to 2.68, marking a decrease of 2.53.
• For EV / EBITDA (X), as of Mar 25, the value is 13.87. This value is within the healthy range. It has decreased from 24.05 (Mar 24) to 13.87, marking a decrease of 10.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.43. This value is within the healthy range. It has decreased from 4.94 (Mar 24) to 2.43, marking a decrease of 2.51.
• For Price / BV (X), as of Mar 25, the value is 4.33. This value exceeds the healthy maximum of 3. It has decreased from 8.72 (Mar 24) to 4.33, marking a decrease of 4.39.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.43. This value is within the healthy range. It has decreased from 4.94 (Mar 24) to 2.43, marking a decrease of 2.51.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness